CTI BioPharma
CTIC
#5841
Rank
โ‚น111.11 B
Marketcap
โ‚น842.55
Share price
0.00%
Change (1 day)
37.00%
Change (1 year)

EPS for CTI BioPharma (CTIC)

EPS in 2023 (TTM): -โ‚น46.96

According to CTI BioPharma 's latest financial reports the company's current EPS (TTM) is -โ‚น53.76. In 2022 the company made an earnings per share (EPS) of -โ‚น78.79 an increase over its 2021 EPS that were of -โ‚น100.11.

EPS history for CTI BioPharma from 2014 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-โ‚น46.96-40.39%
2022-โ‚น78.79-21.3%
2021-โ‚น100.1145.95%
2020-โ‚น68.597.25%
2019-โ‚น63.9630.19%
2018-โ‚น49.13-58.91%
2017-โ‚น119.57-29.12%
2016-โ‚น168.70-72.84%
2015-โ‚น621.026.35%
2014-โ‚น583.95

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
โ‚น486.62-1,005.17%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
โ‚น2,863-5,426.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น1,611-3,096.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-โ‚น130.69 143.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
โ‚น194.65-462.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น418.96-879.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น41.71-177.59%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel